A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia

Conditions: Negative Symptoms in Schizophrenia Interventions: Drug: Roluperidone 64 mg; Drug: Olanzapine 10 MG Sponsors: Minerva Neurosciences Recruiting

https://clinicaltrials.gov/study/NCT06107803

Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials